Saniona borrows USD 10m for clinical studies

The loan will be used to finance the clinical development of the biotech company's assets.

Rami Levin, President & Chief Executive Officer of Saniona | Photo: Saniona / PR

Biotech company Saniona has secured resources to continue the development of the company's assets as well as support general operations.

The listed company reports that it has taken out a non-dilutive term loan of USD 10m from asset manager Formue Nord.

Read the whole article

Get 14 days free access.
No credit card required.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Pfizer upgrades guidance for sales of covid-19 vaccine

The US pharmaceutical company Pfizer now predicts sales of its coronavirus vaccines will total USD 33.5bn this year. The previous estimate was UDS 26bn. Meanwhile, the company has revealed the guidance for its annual revenue.

Further reading

Related articles

Trial banner

Latest news

See all jobs